Back

Prognostic implications of pathogenic truncating variants in the TTN gene

27 August 2018 (17:30 - 17:45)
Organised by:
Congress Presentation Part of: The potential of new and unusual biomarkers in heart failure Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Marcos Nicolas Cicerchia

Blueprint Genetics, a Quest Diagnostics Company, Espoo (Finland)

3 More presentations in this session

Presentation thumbnail
Carpal tunnel syndrome is associated with an increased risk of heart failure carrying a poor prognosis
Doctor E. Fosbol (Copenhagen, DK)
Abstract
Presentation thumbnail
Circulating miRNAs as a prognostic tool for heart failure related morbidity and mortality in patients suffering from stable HFpEF: a subgroup analysis of the ALDO-DHF trial
Mr J. Petutschnigg (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Vocal biomarker predicts long term survival among heart failure patients
Doctor E. Maor (Tel Aviv, IL)
Abstract Slides Video

Access the full session

Session thumbnail
The potential of new and unusual biomarkers in heart failure

The Event

Event poster

ESC Congress 2018

27 August 2018 17:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources